Related consortia

tEPIS is part of the LSH-FES consortium since 2012. Below are the rest of the related consortia in the portfolio of LSH:

The Netherlands Institute for Regenerative Medicine (NIRM) combines cutting-edge research in stem cell biology with advances in tissue engineering, so as to improve existing and create novel regenerative medical treatments. Read more:


NeuroBasic-PharmaPhenomics wants to build new rodent models of neurological and psychiatric diseases and translate pre-clinical studies of animal models into novel treatments for human patients. Read more:


The mission of the VIRGO project is the rational design of vaccination and other intervention strategies for respiratory virus infections.
Read more:

The mission of DCTI is to improve beta-cell replacement therapy and to make this therapy accessible for more patients with diabetes. The main research goals are to increase the availability of high quality islets for transplantation, identify factors for long-term islet function and survival, and to develop alternative transplantation sites with the use of biomaterials.
Read more:


Towards better diagnostic tools: integrating bioimaging technologies

How can molecular alterations affect the healthy state of a human being? It is essential to understand this in order to develop new diagnostics and treatments. Yet answering this question requires an all embracing picture – from molecules to cells to organs to organisms.

Current bioimaging tools can only reveal the important aspects on one single level. In Cyttron II tools are developed and the quantitative data of complementary bioimaging technologies are integrated in order to understand the whole picture.
Read more:


This consortium is part of the LSH-FES portfolio. Life Sciences Health (LSH) is the national cluster organization of the Dutch life sciences & health sector.

Read more: